Shechter Y - Search Results

1

Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.

Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, Nevo N, Biton I, Bach M, Berkutzki T, Fridkin M, Benayahu D, Shechter Y, Stern N. Marcus Y, et al. Among authors: shechter y. Diabetes. 2013 Apr;62(4):1121-30. doi: 10.2337/db12-0792. Epub 2012 Dec 18. Diabetes. 2013. PMID: 23250359 Free PMC article.

2

New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin.

Gershonov E, Shechter Y, Fridkin M. Gershonov E, et al. Among authors: shechter y. Diabetes. 1999 Jul;48(7):1437-42. doi: 10.2337/diabetes.48.7.1437. Diabetes. 1999. PMID: 10389850

3

Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin.

Marcus Y, Sasson K, Fridkin M, Shechter Y. Marcus Y, et al. Among authors: shechter y. J Med Chem. 2008 Jul 24;51(14):4300-5. doi: 10.1021/jm8002558. Epub 2008 Jun 25. J Med Chem. 2008. PMID: 18578475

4

Establishing the principle of reversibility in peptide/protein and small-molecule therapy.

Shechter Y, Sasson K, Marcus Y, Rubinraut S, Lev-Goldman V, Fridkin M. Shechter Y, et al. Ther Deliv. 2012 Jan;3(1):17-23. doi: 10.4155/tde.11.133. Ther Deliv. 2012. PMID: 22833930 Review.

5

Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions.

Sasson K, Marcus Y, Lev-Goldman V, Rubinraut S, Fridkin M, Shechter Y. Sasson K, et al. Among authors: shechter y. J Control Release. 2010 Mar 3;142(2):214-20. doi: 10.1016/j.jconrel.2009.10.028. Epub 2009 Oct 30. J Control Release. 2010. PMID: 19883707

6

Delivery of neuropeptides from the periphery to the brain: studies with enkephalin.

Shechter Y, Heldman E, Sasson K, Bachar T, Popov M, Fridkin M. Shechter Y, et al. ACS Chem Neurosci. 2010 May 19;1(5):399-406. doi: 10.1021/cn100001j. Epub 2010 Feb 16. ACS Chem Neurosci. 2010. PMID: 22778833 Free PMC article.

7

Insulin-like effects of vanadium: basic and clinical implications.

Goldwaser I, Gefel D, Gershonov E, Fridkin M, Shechter Y. Goldwaser I, et al. Among authors: shechter y. J Inorg Biochem. 2000 May 30;80(1-2):21-5. doi: 10.1016/s0162-0134(00)00035-0. J Inorg Biochem. 2000. PMID: 10885459 Review.

8

Reversible pegylation of insulin facilitates its prolonged action in vivo.

Shechter Y, Mironchik M, Rubinraut S, Tsubery H, Sasson K, Marcus Y, Fridkin M. Shechter Y, et al. Eur J Pharm Biopharm. 2008 Sep;70(1):19-28. doi: 10.1016/j.ejpb.2008.03.018. Epub 2008 Apr 7. Eur J Pharm Biopharm. 2008. PMID: 18495444

9

Suspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats.

Shechter Y, Tsubery H, Fridkin M. Shechter Y, et al. Biochem Biophys Res Commun. 2003 Jul 25;307(2):315-21. doi: 10.1016/s0006-291x(03)01200-2. Biochem Biophys Res Commun. 2003. PMID: 12859957

10

Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.

Cooper I, Sasson K, Teichberg VI, Schnaider-Beeri M, Fridkin M, Shechter Y. Cooper I, et al. Among authors: shechter y. J Biol Chem. 2012 Dec 28;287(53):44676-83. doi: 10.1074/jbc.M112.395384. Epub 2012 Nov 13. J Biol Chem. 2012. PMID: 23150670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters